To systematically model PI3K pathway alterations and study p110 isoform dependencies in mCRPC, we evaluated a broad collection of patient-derived prostate cancer organoids (PDOs) established from metastatic tumor biopsies of mCRPC patients30. The gene discussed is PIK3CA; the disease is prostate carcinoma.